Earnings Releases·Nov 10, 2026, 4:05 PM ET

Lumexa Imaging — Third Quarter 2026 Earnings Summary

Consolidated revenue reached $272.0 million, up 5.0% year-over-year, while net income turned positive at $7.2 million compared to a $3.5 million loss in the prior year period.
Adjusted EBITDA guidance for full-year 2026 was narrowed to $236 million–$240 million, and Adjusted EPS guidance was raised to $0.86–$0.90 per share.
Full-year consolidated revenue guidance remains reiterated at $1.045 billion to $1.097 billion, with management targeting 8–10 new center openings in 2026.
Operating cash flow improved significantly to $70.5 million for the nine months ended September 30, 2026, driven by a reduction in interest expense to $15.7 million from $30.6 million year-over-year.